What does current research say about cannabis and migraines?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Interest in cannabis and migraine research has grown in recent years as patients and scientists look for alternative ways to manage chronic headache disorders. While anecdotal reports are common, clinical research is gradually providing more structured insight into how cannabis may help reduce migraine symptoms.

Though still developing, cannabis and migraine research suggests cannabinoids may influence pain, inflammation, and serotonin signalling , all of which play a role in migraine onset and intensity. As more studies emerge, confidence in cannabis-based interventions is beginning to grow.

Highlights from Recent Research

Here are some of the most noteworthy findings from ongoing cannabis studies for migraines.

Pain and frequency reduction

Several patient surveys and observational studies report that cannabis use may reduce both the intensity and frequency of migraine attacks. These results support further cannabis clinical trials on migraine.

Cannabinoid preference

Some studies suggest that patients often prefer strains high in CBD or balanced CBD/THC ratios, finding better tolerability and fewer side effects than THC-dominant options.

Fewer side effects than traditional meds

In some reports, cannabis users noted fewer side effects compared to opioids or triptans, supporting its reputation as a potentially safer alternative in certain cases.

Limited randomised trials

Despite promising early data, the lack of large-scale, placebo-controlled trials means migraine and cannabis scientific evidence remains limited. Researchers are calling for more rigorous investigation.

As it stands, cannabis and migraine research continue to evolve, offering early promise but requiring stronger data to shape clinical guidelines and everyday treatment plans.

If you’re exploring cannabis treatment options for migraines, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and migraines.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.